Identification of routine mycobacterial isolates by gas-liquid chromatograph profile analysis was performed on 335 strains received at the Mayo Clinic over a 10-month period. Comparison of identification by gas-liquid chromatography versus conventional biochemical profiles was made. The two methods agreed on the identification of 320 isolates, with gas-liquid chromatograph profiling making eight errors and biochemical profiling making four errors. In three cases, discrepancies could not be resolved.
We have previously described the successful identification of mycobacteria by analysis of profiles obtained with gas-liquid chromatography (GLC) (2) . Since that report, the method has been transferred from our developmental laboratory to the routine mycobacteriology laboratory, and all subsequent results were obtained and interpreted by personnel in that laboratory. This study reports our clinical laboratory experience with the gas-liquid chromatographic identification of mycobacteria at a routine level over a 10-month period.
Of a total of 340 organisms received at the Mayo Clinic from July 1979 through May 1980, 335 were analyzed by GLC. All organisms were recovered from clinical specimens in our laboratory, except for 16 strains obtained from the College of American Pathologists microbiology proficiency testing program. Culture of organisms and methods of biochemical identification have been previously described, and preparation of organisms and chromatographic conditions used in analysis have remained unchanged from those described previously (2) .
Because the emphasis in routine clinical use is on the earliest possible identification, the scaleddown method (method B) previously described (2) of sample preparation with a 1-mm loopful of organisms was employed. Most of the patients with mycobacterial infections seen at the Mayo Clinic do not represent the type of recalcitrant infection with cavitary lesions containing numerous organisms that are seen in large urban hospitals and clinics. Most specimens sent to our laboratory yield only a few colonies of mycobacteria, and it is usually necessary to subculture the organism to obtain adequate growth for biochemical testing; however, the requirement for minimal colonial growth permitted the application of GLC. Interpretation of GLC profiles was unchanged from our original identification scheme. The frequent use of the method for cultures having scant growth or contamination sometimes gave GLC profiles of poor quality; characteristic peaks of low intensity under optimal conditions were sometimes obscure. This, along with the possible medical importance of any given identification, made us somewhat more conservative in the interpretation of a profile. The species identification and differentiation of Mycobacterium tuberculosis from Mycobacterium bovis and Mycobacterium xenopi was not attempted. Separation of Mycobacterium avium complex from Mycobacterium gastri and Mycobacterium scrofulaceum was not made. Mycobacterium fortuitum and Mycobacterium chelonei were combined into the M. fortuitum-chelonei complex as suggested by Wolinsky (3) .
GLC performance was assessed at the end of the 10-month study period by comparing the identifications made by GLC profile with those made by biochemical profile. The initial interpretation of the GLC profile was subsequently reviewed by a second observer who had no prior knowledge of the culture. No disagreements occurred with respect to the original interpretations. Resolution of discrepancies between GLC identification and biochemical identification was attempted by further biochemical testing and repeat chromatographic analysis of fully matured colonies (Table 1) .
It can be seen that there were 15 instances of the 335 strains tested in which the GLC identification did not match the biochemical identification. Of these 15 discrepancies, biochemical testing was shown to be correct in 8 instances. In seven of these eight GLC errors, the GLC pattern was read as M. fortuitum. The M. fortui- The GLC profiles in these last three cases showed either an uninterpretable pattern or the core pattern without unique peaks that would be interpreted as M. fortuitum complex. The excellent performance of GLC identification is readily apparent. Of 335 strains, 223 were correctly identified without ambiguity, and an additional 95 were placed into one of two groups in which the best guess could be made on the basis of the most probable organism, as in the case of the M. tuberculosis-M. bovis-M. xenopi grouping or absence of pigment production for most M. avium strains in the M. avium-M. scrofulaceum-M. gastri grouping. Of the organisms, 67% (223 of 335) were correctly identified, and an additional 28% (95 of 335) were guessed with a reliability that exceeded 90%. The identification of isolates to complex level is sufficient for most J. CLIN. MICROBIOL. Identification of clinical mycobacterial isolates by GLC has now become an integral part of our routine mycobacteriology laboratory. The processing of a specimen takes approximately 1 h from start to finish. It gives a result days to weeks faster than conventional biochemical testing (2). The GLC pattern for M. tuberculosis is now used as a presumptive identification; however, the identification is still confirmed by biochemical testing. In terms of other species, the GLC identification can be used to direct biochemical tests (Table 2) . For example, a GLC identification of M. fortuitum complex, which is consistent with colonial morphology and growth rate, would require only a positive arylsulfatase for definite complex identification and a positive nitrate test for species identification. We feel that GLC is an easy and rapid method to use for the identification of clinically important mycobacteria.
